Correction to Previous CBDfx E-Liquid Review | 2026 THC & CBN Regulations and Inhalation Risk Checkpoints

Corrected on 2026-10-20:We have retracted the purchase recommendations and efficacy claims for CBDfx e-liquid from our original 2020 publication. Specifications and prices from that time, such as 30ml and 1,000mg, do not guarantee currently distributed products or regulatory compliance as of 2026. The original publication date is retained.

Precautions When Reading Articles on Overseas CBD E-Liquids from 2020

In Japan, residual limits for Δ9-THC (10ppm for oils and powders, 0.10ppm for aqueous solutions, and 1ppm for others) took effect on 2024-12-12, and CBN became a designated substance on 2026-6-1. Descriptions from 2020 such as 'THC-free' or 'full-spectrum / broad-spectrum' do not mean the product was tested under current Japanese legal standards.

Additionally, flavored VAPE e-liquids tend to encourage more frequent puffing because they are easy to inhale, so sufficient caution is required regarding airway irritation from inhaling heated aerosols and the risk of excessive CBD intake.

CBD, THC, and CBN Are Different Substances: Check the 2026 Regulations

CBD (cannabidiol), CBN (cannabinol), and Δ9-THC are distinct compounds treated differently under Japanese law. Product names or package labels such as "CBD Product" or "Hemp-Derived" alone cannot determine all contained ingredients or legal compliance.

CBN became a designated substance on 2026-6-1.The Ministry of Health, Labour and Welfare prohibits in principle the manufacture, import, sale, possession, and use of CBN-containing products. While procedural exceptions exist for medical and research uses, they do not permit general consumer purchase or use. Do not rely on older reviews or past articles claiming "legal" or "recommended." Source:Ministry of Health, Labour and Welfare: Designation of CBN and Procedures.

In addition, category-specific residual limits for Δ9-THC took effect on 2024-12-12, and any product exceeding the threshold is classified as a narcotic. These figures are product concentration standards, not intake guidelines.

Product appearance or naming alone does not determine whether an item falls under the oils/fats category. You must verify the actual product category against a lot-specific Certificate of Analysis (COA). Source:Ministry of Health, Labour and Welfare: Legal Amendments and Residual Limits.

4 Certificate of Analysis (COA) Checkpoints Before Purchase or Use

• Match Between Product Name and Batch / Lot Number:Whether the lot number printed on your actual container matches the lot number on the report rather than a generic sample certificate.
• Testing Laboratory and Analysis Date:Whether the name of the third-party laboratory, date of testing, and analytical method are clearly stated.
• Limit of Quantification (LOQ) and Limit of Detection (LOD) for Δ9-THC:Whether testing sensitivity is below Japan's category-specific residual limits (10ppm / 0.10ppm / 1ppm), rather than merely stating "ND (Not Detected)."
• Absence of Designated Substances (Such as CBN) and Undeclared Ingredients:Whether CBN, a designated substance since 2026-6-1, is confirmed absent.

Avoid using products without verifiable lot numbers or items from unverified sources such as social media or flea-market apps, as actual contents may differ from the label.

Why "Safe Because It Is CBD" or "Side-Effect-Free Because It Is Natural" Cannot Be Assumed

The U.S. FDA highlights risks associated with CBD including liver injury, interactions with concurrent medications, pronounced drowsiness, diarrhea, and appetite changes, while noting scientific unknowns regarding long-term use and differences across intake routes (inhalation, oral, topical). Source:FDA: Risks and Unknowns of CBD Products.

Research on specific prescription CBD formulations cannot be treated as proof that commercial CBD oils, gummies, or VAPE liquids improve insomnia, relieve stress, boost immunity, or aid smoking cessation. Discontinue use immediately and consult a medical professional if you feel unwell. Anyone with preexisting conditions or taking medication should consult a physician or pharmacist rather than self-medicating.

Related:CBD Liquid Cautions and Risks | Why to Avoid Unverified Products